KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Income from Continuing Operations: 2010-2025

Historic Income from Continuing Operations for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -$202.4 million.

  • Novavax's Income from Continuing Operations fell 66.84% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 219.97%. This contributed to the annual value of -$187.5 million for FY2024, which is 65.60% up from last year.
  • Latest data reveals that Novavax reported Income from Continuing Operations of -$202.4 million as of Q3 2025, which was down 290.01% from $106.5 million recorded in Q2 2025.
  • Novavax's Income from Continuing Operations' 5-year high stood at $518.6 million during Q1 2025, with a 5-year trough of -$846.3 million in Q4 2021.
  • Its 3-year average for Income from Continuing Operations is -$28.2 million, with a median of -$121.3 million in 2024.
  • As far as peak fluctuations go, Novavax's Income from Continuing Operations slumped by 1,910.83% in 2021, and later skyrocketed by 451.51% in 2025.
  • Quarterly analysis of 5 years shows Novavax's Income from Continuing Operations stood at -$846.3 million in 2021, then surged by 78.46% to -$182.2 million in 2022, then grew by 2.12% to -$178.4 million in 2023, then surged by 54.58% to -$81.0 million in 2024, then plummeted by 66.84% to -$202.4 million in 2025.
  • Its Income from Continuing Operations was -$202.4 million in Q3 2025, compared to $106.5 million in Q2 2025 and $518.6 million in Q1 2025.